MA23118A1 - Procede pour la preparation de compositions de vaccins contre la grippe . - Google Patents

Procede pour la preparation de compositions de vaccins contre la grippe .

Info

Publication number: MA23118A1
Authority: MA; Morocco
Prior art keywords: preparation; vaccine compositions; influenza vaccine; influenza; compositions
Prior art date: 1993-02-19

Application number

MA23425A

Other languages

English (en)

Inventor

Dillon Susan

J Grurick Robert

Nishikawa Hirotoshi

Dal Monte Paul

Marie Joseph Claude G Nathalie

Original Assignee

Smithkline Beecham Biolog

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-02-19

Filing date

1994-02-17

Publication date

1994-10-01

1994-02-17 Application filed by Smithkline Beecham Biolog, Smithkline Beecham Corp filed Critical Smithkline Beecham Biolog

1994-10-01 Publication of MA23118A1 publication Critical patent/MA23118A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Virology (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

MA23425A 1993-02-19 1994-02-17 Procede pour la preparation de compositions de vaccins contre la grippe . MA23118A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2153593A	1993-02-19	1993-02-19
US11575093A	1993-09-01	1993-09-01

Publications (1)

Publication Number	Publication Date
MA23118A1 true MA23118A1 (fr)	1994-10-01

Family

ID=26694802

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA23425A MA23118A1 (fr)	1993-02-19	1994-02-17	Procede pour la preparation de compositions de vaccins contre la grippe .

Country Status (9)

Country	Link
EP (1)	EP0684838A1 (fr)
AP (1)	AP431A (fr)
AU (1)	AU6141094A (fr)
CA (1)	CA2156525A1 (fr)
IL (1)	IL108681A0 (fr)
MA (1)	MA23118A1 (fr)
MX (1)	MX9401225A (fr)
SI (1)	SI9400085A (fr)
WO (1)	WO1994019013A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9105992D0 (en) *	1991-03-21	1991-05-08	Smithkline Beecham Biolog	Vaccine
US5776468A (en) *	1993-03-23	1998-07-07	Smithkline Beecham Biologicals (S.A.)	Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A
UA56132C2 (uk) *	1995-04-25	2003-05-15	Смітклайн Бічем Байолоджікалс С.А.	Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US6306404B1 (en)	1998-07-14	2001-10-23	American Cyanamid Company	Adjuvant and vaccine compositions containing monophosphoryl lipid A
GB9820525D0 (en) *	1998-09-21	1998-11-11	Allergy Therapeutics Ltd	Formulation
US6261573B1 (en) *	1998-10-30	2001-07-17	Avant Immunotherapeutics, Inc.	Immunoadjuvants
AT407958B (de) *	1999-02-11	2001-07-25	Immuno Ag	Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
US6635261B2 (en)	1999-07-13	2003-10-21	Wyeth Holdings Corporation	Adjuvant and vaccine compositions containing monophosphoryl lipid A
GB9923176D0 (en) *	1999-09-30	1999-12-01	Smithkline Beecham Biolog	Novel composition
RU2164148C1 (ru) *	2000-08-09	2001-03-20	Петров Рэм Викторович	Вакцина против вируса гриппа и способ ее получения
ATE503493T1 (de) *	2001-02-23	2011-04-15	Glaxosmithkline Biolog Sa	Influenza vakzinzusammensetzungen zur intradermaler verabreichung
WO2002067983A1 (fr) *	2001-02-23	2002-09-06	Glaxosmithkline Biologicals S.A.	Nouveau vaccin
US20060058736A1 (en) *	2001-04-27	2006-03-16	Alchas Paul G	Novel vaccine
SI2578229T1 (sl)	2004-09-09	2013-10-30	Novartis Vaccines And Diagnostics Gmbh	ZmanjĹˇanje potencialnih iatrogenih tveganj, povezanih z antigeni cepiv
WO2006062637A2 (fr)	2004-11-03	2006-06-15	Novartis Vaccines And Diagnostics Inc.	Vaccination antigrippale
TW200700078A (en)	2005-03-23	2007-01-01	Glaxosmithkline Biolog Sa	Novel use
MX2009000660A (es)	2006-07-17	2009-04-08	Glaxosmithkline Biolog Sa	Vacuna de influenza.
BRPI0721393B8 (pt) *	2007-03-22	2022-09-06	Fund Butantan	método para obter lipídeo a monofosforilado da bordetella pertussis como um subproduto da produção de vacina celular contra coqueluche
US9452209B2 (en)	2007-04-20	2016-09-27	Glaxosmithkline Biologicals Sa	Influenza vaccine
AU2009227674C1 (en) *	2008-03-18	2015-01-29	Seqirus UK Limited	Improvements in preparation of influenza virus vaccine antigens
AU2011300402B2 (en)	2010-09-07	2015-01-22	Novartis Ag	Generic assays for detection of mammalian reovirus
EP2653156A1 (fr) *	2012-10-01	2013-10-23	College of Pharmacy of Taif University	Composition d'émulsion pharmaceutique et son utilisation
AU2014388299A1 (en) *	2014-03-25	2016-10-20	The Government Of The United States Of America As Represented By The Secretary Of The Army	Methods for enhancing the immunostimulation potency of aluminum salt-adsorbed vaccines
WO2020010394A1 (fr)	2018-07-10	2020-01-16	Seqirus Pty Ltd	Élimination d'agglomérats
CN112361796A (zh) *	2020-11-13	2021-02-12	安徽省天长市周氏羊业有限公司	一种秸秆回收储存前破碎干燥装置
CN114989269B (zh) *	2022-06-30	2023-09-19	天康制药股份有限公司	一种牛赤羽免疫原性抗原及疫苗

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL79114A (en) *	1985-08-07	1990-09-17	Allergan Pharma	Method and composition for making liposomes
US5230899A (en) *	1985-08-07	1993-07-27	Smithkline Beecham Corporation	Methods and compositions for making liposomes
US4912094B1 (en) *	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
NZ230423A (en) *	1988-08-25	1993-08-26	Liposome Co Inc	A dosage form comprising an antigen and a multilamellar liposome comprising dimyristolyphosphatidylcholine (dmpc) and cholesterol
DK425789A (da) *	1988-08-31	1990-03-01	Smithkline Beecham Corp	Vaccinale polypeptider
AU640348B2 (en) *	1988-08-31	1993-08-26	Smithkline Beecham Corporation	Vaccinal Polypeptides
AU654970B2 (en) *	1990-09-28	1994-12-01	Smithkline Beecham Biologicals (Sa)	Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
JPH06503821A (ja) *	1990-12-20	1994-04-28	スミスクライン・ビーチャム・バイオロジカルス（ソシエテ・アノニム）	Ｂ型肝炎表面抗原に基づくワクチン
FR2671974A1 (fr) *	1991-01-24	1992-07-31	Pasteur Merieux Serums Vacc	Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.
GB9105992D0 (en) *	1991-03-21	1991-05-08	Smithkline Beecham Biolog	Vaccine
NZ253137A (en) *	1992-06-25	1996-08-27	Smithkline Beecham Biolog	Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a.

1994
- 1994-02-15 AU AU61410/94A patent/AU6141094A/en not_active Abandoned
- 1994-02-15 EP EP94908327A patent/EP0684838A1/fr not_active Withdrawn
- 1994-02-15 CA CA002156525A patent/CA2156525A1/fr not_active Abandoned
- 1994-02-15 WO PCT/EP1994/000448 patent/WO1994019013A1/fr not_active Ceased
- 1994-02-17 MA MA23425A patent/MA23118A1/fr unknown
- 1994-02-17 MX MX9401225A patent/MX9401225A/es unknown
- 1994-02-17 IL IL10868194A patent/IL108681A0/xx unknown
- 1994-02-17 AP APAP/P/1994/000621A patent/AP431A/en active
- 1994-02-18 SI SI9400085A patent/SI9400085A/sl unknown

Also Published As

Publication number	Publication date
MX9401225A (es)	1994-08-31
SI9400085A (en)	1994-09-30
IL108681A0 (en)	1994-05-30
AU6141094A (en)	1994-09-14
CA2156525A1 (fr)	1994-09-01
WO1994019013A1 (fr)	1994-09-01
AP431A (en)	1995-11-15
AP9400621A0 (en)	1994-04-30
EP0684838A1 (fr)	1995-12-06

Publication	Publication Date	Title
MA23118A1 (fr)	1994-10-01	Procede pour la preparation de compositions de vaccins contre la grippe .
MA23143A1 (fr)	1994-10-01	Procede pour la preparation de compositions vaccinantes .
MA22842A1 (fr)	1993-10-01	Procede de preparation de compositions de vaccin.
MA23850A1 (fr)	1996-12-31	Procede de preparation de compositions vaccinantes
MA23918A1 (fr)	1996-12-31	Procede de preparation de compositions vaccinantes
MA23814A1 (fr)	1996-10-01	Procede de preparation de compositions vaccinantes
MA22911A1 (fr)	1993-12-31	Procede de production de formulations de vaccins.
EP1242464A4 (fr)	2004-06-16	Procede de preparation de produits polyolefiniques
MA23528A1 (fr)	1995-12-31	Procede de preparation de produits pharmaceutiques
MA23395A1 (fr)	1995-07-01	Procede de preparation de nouvelles formulations
MA24291A1 (fr)	1998-04-01	Procede pour la preparation de compositions de vaccin
HUP9603494A3 (en)	2000-08-28	Hydroxycarboxamide derivatives, pharmaceutical compositions containing them, process for the preparation thereof
FR2788780B1 (fr)	2001-03-30	Procede de preparation de vesicules membranaires
MA25223A1 (fr)	2001-07-02	Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine
MX9204546A (es)	1993-02-01	Proceso para la preparacion de natamicina por fermentacion.
MA22381A1 (fr)	1992-07-01	Procede de production de vaccins
MA23518A1 (fr)	1995-12-31	Procede de preparation de produits pharmaceutiques
IS3814A (is)	1992-08-14	Aðferð til framleiðslu á lyfjablöndum
EP1023250A4 (fr)	2001-03-21	Procede de preparation de 2,6-dialkylnaphtalene
MA23663A1 (fr)	1996-04-01	Procede de preparation de formulations pharmaceutiques
FR2818979B1 (fr)	2003-05-30	Procede de preparation d'imidaclopride
FI954931A0 (fi)	1995-10-17	Uusia piperidinyylitioindolin johdannaisia, niiden valmistusmenetelmä, niitä sisältäviä farmaseuttisia koostumuksia, jotka ovat käyttökelpoisia erityisesti kivun lievittäjinä
MA22880A1 (fr)	1993-12-31	Procede de preparation de produits pharmaceutiques .
FR2728268B1 (fr)	1997-04-04	Procede de preparation de gamma-cyclodextrine
DZ2746A1 (fr)	2003-09-08	Nouveau procédé de préparation de la fexofénadine.